Home › Research › Tau biomarkers
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease
López-Cuevas R, Baquero-Toledo M, Cuevas-Jiménez A, Martín-Ibáñez N, Pascual-Costa R, Moreno-Monedero MJ, Cañada-Martínez A, Peña-Bautista C et al.. Neurologia, 2023-04-07
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
We performed a retrospective analysis of the patients assessed at our memory unit for whom Alzheimer disease (AD) cerebrospinal fluid biomarker results were available. We selected patients diagnosed with mild cognitive impairment due to AD (National Institute on Aging-Alzheimer's Association clinical criteria), confirmed neuropsychological deficit, a Global Deterioration Scale score of 3, and an abnormal profile of cerebrospinal fluid biomarkers. Of the 588 cases reviewed, 110 met the inclusion criteria.
What this study adds
Evidence grade: Low
In this retrospective analysis of 110 patients with mild cognitive impairment due to Alzheimer's disease, higher baseline total and phosphorylated tau levels were found in those who progressed to dementia. Reported effect size: 45.45%; 7.60%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
López-Cuevas, R., Baquero-Toledo, M., Cuevas-Jiménez, A., Martín-Ibáñez, N., Pascual-Costa, R., Moreno-Monedero, M. J., et al. (2023). Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease. Neurologia. https://doi.org/10.1016/j.nrleng.2020.07.024
Vancouver
López-Cuevas R, Baquero-Toledo M, Cuevas-Jiménez A, Martín-Ibáñez N, Pascual-Costa R, Moreno-Monedero MJ, et al. Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease. Neurologia. 2023. doi:10.1016/j.nrleng.2020.07.024. PMID: 37031800.
BibTeX
@article{lopezcuevas2023-37031800,
author = {López-Cuevas, R. and Baquero-Toledo, M. and Cuevas-Jiménez, A. and Martín-Ibáñez, N. and Pascual-Costa, R. and Moreno-Monedero, M. J. and Cañada-Martínez, A. and Peña-Bautista, C. and others},
title = {{Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease}},
journal = {Neurologia},
year = {2023},
doi = {10.1016/j.nrleng.2020.07.024},
pmid = {37031800},
url = {https://doi.org/10.1016/j.nrleng.2020.07.024}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We selected patients diagnosed with mild cognitive impairment due to AD (National Institute on Aging-Alzheimer's Association clinical criteria), confirmed neuropsychological deficit, a Global Deterioration Scale score of 3, and an abnormal profile of cerebrospinal fluid biomarkers.
- Of the 588 cases reviewed, 110 met the inclusion criteria.
- During follow-up, 50 cases (45.45%) progressed to dementia due to AD.
- Baseline levels of total and phosphorylated tau were higher in the group of patients that progressed to dementia than in those remaining with mild cognitive impairment.
Why it matters
In this retrospective analysis of 110 patients with mild cognitive impairment due to Alzheimer's disease, higher baseline total and phosphorylated tau levels were found in those who progressed to dementia. This is prognostic information only and does not report any treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Effect size45.45%; 7.60%
- Evidence strengthLow
How this study scored 32/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neurologia) |
| Journal's citation record | 0 / 4 | Neurología (English Edition): journal h-index 47 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.6 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 1 / 6 | Cited 0.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Consuelo Cháfer‐Pericás: h-index 33 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Hospital Universitari i Politècnic La Fe: institution h-index 376 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37031800) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 32 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.nrleng.2020.07.024
- PubMed: 37031800
- Original source →
- Free full text: Neurología (English Edition) →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.